4829-34-9 Usage
Description
1-(2-bromo-4,5-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline is a chemical compound that belongs to the class of isoquinoline alkaloids. It is a derivative of tetrahydroisoquinoline and contains a bromine atom, as well as multiple methoxy groups. 1-(2-bromo-4,5-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline has potential biological activity and may be used in medicinal or pharmaceutical applications. Its structure suggests that it may have pharmacological properties, and further research is needed to investigate its potential uses in the medical field.
Uses
Used in Pharmaceutical Applications:
1-(2-bromo-4,5-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline is used as a potential pharmaceutical agent for its possible biological activity. The presence of a bromine atom and multiple methoxy groups in its structure may contribute to its pharmacological properties, making it a candidate for further research and development in the medical field.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 1-(2-bromo-4,5-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline is used as a compound of interest for exploring its potential therapeutic applications. Its unique structure may provide insights into the development of new drugs targeting various diseases and conditions.
Used in Drug Synthesis:
As a derivative of tetrahydroisoquinoline, 1-(2-bromo-4,5-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline may be used as a building block or intermediate in the synthesis of other pharmaceutically relevant compounds. Its structural features could be exploited to create novel drugs with improved efficacy and selectivity.
Used in Drug Delivery Systems:
Similar to other bioactive compounds, 1-(2-bromo-4,5-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline could be incorporated into drug delivery systems to enhance its bioavailability, targeting, and overall therapeutic efficacy. This may involve the use of nanoparticles, liposomes, or other advanced drug delivery technologies to improve the compound's performance in clinical settings.
Check Digit Verification of cas no
The CAS Registry Mumber 4829-34-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,8,2 and 9 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 4829-34:
(6*4)+(5*8)+(4*2)+(3*9)+(2*3)+(1*4)=109
109 % 10 = 9
So 4829-34-9 is a valid CAS Registry Number.
4829-34-9Relevant articles and documents
Enantioselective synthesis of tetrahydroprotoberberines and bisbenzylisoquinoline alkaloids from a deprotonated α-aminonitrile
Blank, Nancy,Opatz, Till
, p. 9777 - 9784 (2012/01/30)
Under controlled conditions, 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline- 1-carbonitrile can be quantitatively deprotonated in the α-position. Its alkylation directly furnishes 3,4-dihydroisoquinolines which can serve as starting materials for the preparation of various alkaloids. Here, the preparation of the benzylisoquinolines (+)-laudanidine, (+)-armepavine, and (+)-laudanosine as well as the tetrahydroprotoberberines ( - )-corytenchine and ( - )-tetrahydropseudoepiberberine using Noyori's asymmetric transfer hydrogenation are described. The dimeric alkaloids (+)-O-methylthalibrine and (+)-tetramethylmagnolamine were obtained from nonracemic precursors in Ullmann diaryl ether syntheses.
